Related Experiment Video
Updated: Sep 9, 2025

Phage Phenomics: Physiological Approaches to Characterize Novel Viral Proteins
Published on: June 11, 2015
Updated phage banks essential to cope with pathogen evolution: Lessons from Klebsiella pneumoniae and their phages
Pallavi Bhat Ajakkala1, Apoorva R Kenjar1, Sujana Prabell1
1Department of Infectious Diseases and Microbial Genomics, Nitte University Centre for Science Education and Research, Nitte (Deemed to be University), Mangaluru, 575018, Karnataka, India.
Background:
Multidrug-resistant Klebsiella pneumoniae (MDR-KP) leads global health concerns as an infectious agent due to many virulence factors, including biofilm formation. The growing urgency for alternative treatment strategies beyond antibiotics has renewed interest in bacteriophages. Pathogen evolution is dynamic and can lead to phage resistance.
Methods:
Bacteriophages were isolated from environmental sources and screened against a panel of 280 MDR- K. pneumoniae clinical isolates (74 from 2018 to 2020 and 167 from 2022-23 and 39 environmental KP isolates). Phages were grouped by host range and DNA fingerprinting. Five candidate phages with unique and broad host coverage were selected for further characterization and genome sequencing.
Results:
Five candidate phages exhibited diverse host range patterns, strong bacteriolytic activity and significant antibiofilm activity even at low multiplicity of infection. Whole genome sequencing analysis revealed phage KPØ6 to be a novel Taipevirus species with low intergenomic similarity to known phages, and it showed the broadest host range on isolates from the 2018-2020 panel. A significant rise in phage resistance among MDR-KP isolate panels of 2018-2020 and 2022-2023 was observed.
Conclusion:
Lytic bacteriophages offer a promising alternative for tackling MDR-KP infections, especially within healthcare environments. The phages characterized in this study demonstrate strong potential for both biocontrol and therapeutic use against MDR-KP, including infections involving biofilms. However, the dynamic nature of bacterial evolution over five years reiterates the need to update phage banks.
Insights
Lytic bacteriophages show promise against multidrug-resistant Klebsiella pneumoniae (MDR-KP) infections, including biofilms. However, bacterial evolution necessitates continuous updates to phage banks for effective treatment.
Area of Science:
- Microbiology
- Infectious Diseases
- Biotechnology
Background:
- Multidrug-resistant Klebsiella pneumoniae (MDR-KP) poses a significant global health threat due to virulence factors like biofilm formation.
- Antibiotic resistance necessitates alternative strategies, driving renewed interest in bacteriophage therapy.
- Bacterial pathogens evolve dynamically, potentially leading to resistance against bacteriophages.
Purpose of the Study:
- To isolate and characterize bacteriophages with lytic activity against MDR-KP.
- To evaluate the antibiofilm efficacy of candidate phages.
- To assess the evolution of phage resistance in MDR-KP over time.
Main Methods:
- Isolation and screening of bacteriophages against 280 MDR-KP clinical isolates.
- Grouping phages by host range and DNA fingerprinting.
- Whole genome sequencing of selected candidate phages.
Main Results:
- Five candidate phages demonstrated broad host range, strong bacteriolytic, and significant antibiofilm activity.
- Phage KPØ6 was identified as a novel Taipevirus with broad host coverage.
- A notable increase in MDR-KP phage resistance was observed between 2018-2020 and 2022-2023.
Conclusions:
- Lytic bacteriophages are a viable alternative for managing MDR-KP infections, particularly in healthcare settings.
- The characterized phages show potential for biocontrol and therapeutic applications against MDR-KP, including biofilm-related infections.
- The rapid evolution of bacterial resistance underscores the importance of regularly updating phage collections.
More Related Videos
Related Concept Videos
Lytic Cycle of Bacteriophages
Lysogenic Cycle of Bacteriophages
Viral Replication: Lysogenic Cycle
DNA Bacteriophages
Viral Replication: Lytic Cycle
Viral Mutations

